IRVINE, Calif.–(BUSINESS WIRE)– #biologics–Immunis named a semifinalist for the National Academy of Medicine’s $1.5 million Healthy Longevity Grand Prize

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.